| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |